Private Equity, VC & Investor
Base10 vs Greenoaks
Structured technology and market comparison · 2026
Direct Feature Comparison
Base10 · vs · GreenoaksUS venture firm backing technology founders in the real economy.
Concentrated long-term venture investor in technology businesses.
Analyze all overlapping signals and tech stacks for Base10 and Greenoaks
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Base10 and Greenoaks?
When comparing Base10 and Greenoaks, both platforms operate within the Private Equity, VC & Investor ecosystem. Base10 is positioned as US venture firm backing technology founders in the real economy, whereas Greenoaks focuses on Concentrated long-term venture investor in technology businesses. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Base10 and Greenoaks?
When evaluating Base10 and Greenoaks, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Base10 and Greenoaks compare?
Base10 is headquartered in US (founded in 2017) with 10–49 employees. Greenoaks is based in US (founded in 2012) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Base10 vs Greenoaks
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Base10
Recent Signals
- ·Tech.eu (European Tech & Deals)Funding
Causa Prima Raises $20M Seed Round
Causa Prima, a company developing an autonomous finance platform for businesses, has raised $20 million in a seed funding round led by Base10 Partners. The round also saw participation from QED Investors and FJ Labs, alongside existing investors Creandum, Kfund and Borusan Ventures. The investment comes just three months after its $10 million pre-seed round, bringing the company's total funding to $30 million. The platform automates financial processes between companies, particularly invoice approvals, dispute resolution and payments. It uses autonomous agents to handle communications and negotiations, aiming to improve working capital management by identifying early-payment discount opportunities. The company already has enterprise customers and over 3,000 active accounts. The new funding will support expansion into the US.
- Causa Prima raised $20 million in a seed round led by Base10 Partners.
- The round included participation from QED Investors, FJ Labs, and existing investors Creandum, Kfund and Borusan Ventures.
- The seed round follows a $10 million pre-seed round three months earlier, totaling $30 million raised.
- ·techcrunchAI in Automotive CRM
Flai's AI dealership software books 50,000 appointments monthly
Flai, an AI-powered CRM platform for car dealerships, has experienced significant growth, now booking 50,000 appointments per month and working with over 10 of the top 50 dealer groups in the US. The company has raised a $27 million Series A funding round led by Base10 Partners, with participation from dealer groups Friedkin Group and Findlay Automotive, Toyota's venture arm, Y Combinator, and First Round Capital. The funding follows a 20x increase in revenue over the past year, driven by deep integration of AI in sales and service operations. Flai's software handles phone calls, emails, texts, outbound campaigns, and appointment scheduling, and can be deployed in as little as 10 days. The startup differentiates itself through rapid implementation and customer support, positioning itself against competitors like Meta's Muse.
- Flai raised $27 million in Series A funding led by Base10 Partners.
- Flai's AI books 50,000 appointments per month and works with over 10 of top 50 dealer groups.
- Flai experienced a 20x increase in revenue over the past year.
Greenoaks
Recent Signals
- ·CNBC TechnologyPrivacy
Coupang dispute raises U.S. tariff pressure on South Korea
A Republican-led House Judiciary report alleges the South Korean government mounted a targeted campaign against U.S.-headquartered Coupang after a 2025 data breach, prompting calls from some U.S. lawmakers and investors for formal trade investigations and potential tariffs. South Korea disputes the report, defends its actions and the scale of the breach, and says it has engaged with U.S. officials. Investors including Greenoaks and Altimeter urged the U.S. Trade Representative to open a Section 301 probe. The dispute comes amid broader U.S.-South Korea tensions over trade commitments, security cooperation and earlier tariff actions.
- House Judiciary Committee Republicans released a report alleging the South Korean government waged a targeted offensive against Coupang following a data breach.
- South Korea levied a 625 billion won (about $409 million) data-privacy fine on Coupang; Seoul says the breach affected 37.55 million people.
- Investors Greenoaks Capital Partners and Altimeter Capital petitioned the U.S. Trade Representative in January to open a Section 301 investigation into South Korea over its treatment of Coupang.
- ·AINews swyxBehavioral simulation and synthetic populations for decision-making
Simile AI: Behavioral Simulation and Scaling Laws
This podcast episode with Simile co-founder and CEO Joon Sung Park explores the company’s work building behavioral foundation models and synthetic populations for simulation. The discussion covers Simile’s methodology (interviews, transaction/observational data, randomized controlled trials, and post-training on causal mechanisms), validated research (a 1,000-person study where digital twins reproduced human behavior ~85% as accurately as the original humans), enterprise use cases (tens of millions of simulations for Fortune 100 clients like CVS), and the broader ambition to scale multi-agent simulations toward society-scale models. The episode also mentions Simile’s recent Series B at a $2B valuation and funding/backers reported in coverage.
- Simile AI is reported to have a Series B at a $2 billion valuation.
- Simile runs tens of millions of simulations for enterprise customers, including Fortune 100 clients like CVS.
- In a representatively sampled 1,000-person study, Simile’s digital twins reproduced human behavior and attitudes about 85% as accurately as the original humans reproduced their own responses.
- ·techcrunchFundraising
Simile Raises $200M Series B at $2B Valuation
Simile, a startup that builds synthetic/simulated users for marketing and product research, raised $200 million in a Series B at a $2 billion valuation. The round, announced July 30, 2026, was led by Greenoaks with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures. The raise comes five months after Simile's $100 million Series A led by Index. Simile was founded by Joon Sung Park and counts CVS among its customers. The company positions its technology as a way to simulate user behavior for research and product testing, attracting growing VC interest in the synthetic-user market.
- Simile closed a $200 million Series B at a $2 billion valuation (announced 2026-07-30).
- The Series B was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures.
- The raise comes five months after Simile announced a $100 million Series A led by Index Ventures.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Base10 and Greenoaks share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks